Phimo International to Invest $159.7 Million in Philippines for Tobacco Production.

Oct.12.2022
Phimo International to invest $159.7 million to establish a production plant for heating tobacco devices in the Philippines.

According to reports, Femto International will invest $159.7 million in the Philippines to establish a production site for manufacturing heating cigarette devices and heating tobacco sticks.


Phimo International is set to produce heated tobacco sticks in the Philippines for the first time. It is estimated that over 20% of adults in the Philippines smoke. Phimo International stated that this investment will use tobacco leaves grown in the Philippines and create 220 employment opportunities.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI Launches IQOS ILUMA i in the Philippines, Debuts via Official Stores and Online Channels
PMI Launches IQOS ILUMA i in the Philippines, Debuts via Official Stores and Online Channels
PMFTC, the Philippine affiliate of Philip Morris International (PMI), has introduced the heated tobacco device IQOS ILUMA i in the Philippines, featuring induction-heating technology and multiple smart functions. PMI aims to increase the share of smoke-free products to around 66% of its net revenues by 2030. Previously, PMFTC had already launched ZYN nicotine pouch products in Manila.
Nov.25 by 2FIRSTS.ai
EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split
EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split
The European Union will abstain from voting at the upcoming 11th session of the WHO Framework Convention on Tobacco Control (COP11) in Geneva, following months of internal disagreement over how to regulate tobacco and nicotine products. The decision marks a rare and public fracture in EU health policy, reportedly driven by the European Commission’s hardline anti-tobacco stance.
Nov.18 by 2FIRSTS.ai
Smoking Rate Drops to 17.9%, Vaping Rate Climbs to 9.3% in South Korea
Smoking Rate Drops to 17.9%, Vaping Rate Climbs to 9.3% in South Korea
The Korea Disease Control and Prevention Agency (KDCA) released its 2025 Community Health Survey results covering more than 230,000 adults. Traditional cigarette smoking dropped to 17.9%, down 1 percentage point from last year, while e-cigarette use increased to 9.3%, up 0.6 points. Overall tobacco product use stood at 22.1%, a slight decline from 2024 but still 0.5 points higher than 2019.
Dec.08 by 2FIRSTS.ai
Australian Federal Police Dismantles WA Illegal Tobacco Network Linked to National Syndicate
Australian Federal Police Dismantles WA Illegal Tobacco Network Linked to National Syndicate
Australian Federal Police (AFP) and Western Australia Police seized more than five tonnes of illicit tobacco products in Perth, including over four million cigarettes, about 50,000 vapes, and nearly 900 kilograms of loose-leaf tobacco. Authorities allege the operation, linked to a national organised crime syndicate, aimed to evade around $8 million in Commonwealth excise and taxes.
Oct.31 by 2FIRSTS.ai
Latvia’s Constitutional Court Upholds Vape Flavor Ban as Constitutional
Latvia’s Constitutional Court Upholds Vape Flavor Ban as Constitutional
The Constitutional Court of Latvia upheld the 2025 vape-flavor ban as constitutional, rejecting appeals by Pro Vape and SIA MASS Industry. Judges said the restrictions serve a legitimate public-health purpose by protecting youth from nicotine addiction and that the social benefits outweigh business losses.
Oct.24 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai